Methods and devices for treatment of eyelid ptosis
OwnerAtif B. D. Collinsinventor
Life of this patent
Estimating the term…
Abstract
Provided herein is a drug eluting device that can be implanted into the Muller's muscle of a subject to elute a sympathetic stimulant such as oxymetazoline, phenylephrine, norepinephrine, adrenaline, or a combination thereof. Also provided herein are methods to use the device and sympathetic stimulant to treat or prevent eyelid ptosis.
Claims8
A drug eluting device for treatment of eyelid ptosis, the drug eluting device having an elongate shape and a length between 3 mm and 4 cm, the drug eluting device comprising a biodegradable polymer and a sympathetic stimulant composition comprising between 0.05 to 5.0 weight percentage of oxymetazoline, wherein the drug eluting device is configured to elute at least 0.2 cc of the sympathetic stimulant composition for at least one month, and wherein the drug eluting device is further configured to be injected into a Muller's muscle of a patient using an injection device configured to allow access to an interior portion of an eye region.
Dependencies are inferred from the claim text.